Gelonghui, March 27丨Hanshang Group (600774.SH) said on an interactive platform that its holding subsidiary Chongqing Dikang Changjiang Pharmaceutical Co., Ltd. holds atropine-related drug approvals (Sinopharm H50020864, Sinopharm H50020865, Sinopharm H50020866), but currently does not produce or sell atropine related pharmaceutical products.
汉商集团(600774.SH)：目前未生产或销售阿托品相关医药产品
Hanshang Group (600774.SH): Currently does not produce or sell atropine related pharmaceutical products
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated